Stock ABLD ABL DIAGNOSTICS
Add to a list
To use this feature you must be a member
Log inSign up

Highlights ABL Diagnostics

Equities

ABLD

FR001400AHX6

Real-time Euronext Paris
Other stock markets
 10:30:20 18/07/2024 BST 		5-day change 1st Jan Change
2.76 EUR -1.43% Intraday chart for ABL Diagnostics 0.00% -71.55%
2023 ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023 CI
2023 ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2022 CI

Highlights

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2023
CI
ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2022
CI
Roche, ABL Diagnostics Sign Distribution Partnership in South Africa
MT
ABL Diagnostics Société anonyme Reports Earnings Results for the Half Year Ended June 30, 2022
CI
Advanced Biological Laboratories S.A. completed the acquisition of a 96.7% stake in ABL Diagnostics Société anonyme (ENXTPA : ABLD) from STE Parisienne De Construction Et De Location and seven natural persons.
CI
ABL Diagnostics Société anonyme Reports Earnings Results for the Full Year Ended December 31, 2021
CI
Advanced Biological Laboratories S.A. agreed to acquire the remaining 3.3% stake in Fauvet-Girel for €0.13 million.
CI
Advanced Biological Laboratories S.A. acquired 96.7% stake in ABL Diagnostics Société anonyme (ENXTPA : ABLD) from STE Parisienne De Construction Et De Location and seven natural persons for €3.9 million.
CI
Advanced Biological Laboratories S.A. acquired 96.7% stake in Fauvet-Girel from STE Parisienne De Construction Et De Location and seven natural persons for €3.9 million.
CI
Fauvet-Girel Reports Earnings Results for the Full Year Ended December 31, 2020
CI
Bernard Krief Consultants SA completed the acquisition of 96.7% stake in Fauvet-Girel from Spaclo SA and members of the founding family.
CI
Bernard Krief Consultants SA signed an agreement to acquire 96.7% stake in Fauvet-Girel from Spaclo SA and members of the founding family for €8.1 million.
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ABLD Stock
  4. News ABL Diagnostics
  5. Highlights